Lyell Immunopharma, Inc. (LYEL)
NASDAQ · Healthcare
Lyell Immunopharma, Inc. Shareholder Equity 2019–2025
Lyell Immunopharma, Inc. annual shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Lyell Immunopharma, Inc. shareholder equity as of December 31, 2025: 248.2M, a 35.17% decrease year-over-year.
- Lyell Immunopharma, Inc. shareholder equity for 2025 were 248.2M, a 35.17% decrease from 2024.
- Lyell Immunopharma, Inc. shareholder equity for 2024 were 382.8M, a 41.55% decrease from 2023.
- Lyell Immunopharma, Inc. shareholder equity for 2023 were 655.0M, a 21.40% decrease from 2022.
- Lyell Immunopharma, Inc. shareholder equity for 2022 were 833.3M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Lyell Immunopharma, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $248 |
| 2024 | $383 |
| 2023 | $655 |
| 2022 | $833 |
| 2021 | $930 |
| 2020 | $-293 |
Lyell Immunopharma, Inc. Shareholder Equity — FAQ
Lyell Immunopharma, Inc. (LYEL) shareholder equity over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LYEL's shareholder equity history?
The chart and table above show Lyell Immunopharma, Inc.'s shareholder equity by year and by quarter, including the growth rate.